| Rebecca J Reed, | |
|
3003 Riverside Dr, Jackson, TN 38301-9160 | |
| (731) 234-4806 | |
| (731) 234-4806 |
| Full Name | Rebecca J Reed |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Addiction (substance Use Disorder) |
| Location | 3003 Riverside Dr, Jackson, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033629209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TA0400X | Psychologist - Addiction (substance Use Disorder) | 1000000020948 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca J Reed, 2999 Riverside Dr, Jackson, TN 38301-9109 Ph: (731) 234-4806 | Rebecca J Reed, 3003 Riverside Dr, Jackson, TN 38301-9160 Ph: (731) 234-4806 |
News Archive
Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography technology, today announces data showing that use of its VivoSight OCT scanner significantly improves diagnosis of basal-cell carcinoma at an earlier stage and reduces diagnostic biopsies by 36%.
A new study from Athens, Greece, describes the use of a deep learning algorithm that uses chest X-rays to diagnose COVID-19 pneumonia.
The John Theurer Cancer Center at Hackensack University Medical Center's Cutaneous Malignancies Program has partnered with The Promise Foundation to host a skin cancer screening event on Thursday, June 2 from 10am -5pm. This program will feature educational information on skin cancer prevention and offer free skin cancer screenings by appointment only for the community.
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
e-Therapeutics plc today provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies, one in patients with primary or secondary brain cancer and the other in patients with various solid tumours, remain on track to report final data in Q4 2013 and Q1 2014, respectively. Interim data from the trials are expected in H1 2013.
› Verified 9 days ago
Jerry Melcher, CLINICAL PSYCHOLOGIS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 50 Bent Creek Ln, Jackson, TN 38305 Phone: 731-661-9109 Fax: 731-661-9110 | |
Chelsey M Wylde, PSY. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-664-1375 Fax: 731-660-8370 | |
Dr. John David Vickery, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3363 Highway 45 North, Jackson, TN 38305 Phone: 731-664-8444 | |
Richard Spring, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 156 W University Pkwy, Ste B, Jackson, TN 38305 Phone: 731-217-3261 Fax: 731-421-2778 | |
Mr. Toby S Altfeld, SPE Psychologist Medicare: Not Enrolled in Medicare Practice Location: 156 C West University Parkway, Jackson, TN 38305 Phone: 731-394-0749 Fax: 731-512-3875 | |
Dr. Bobby L. Raines, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1903 N Highland Ave, Jackson, TN 38305 Phone: 731-427-0416 |